Symbol | Exchange | Currency |
|---|
BMO Capital analyst Do Kim maintained a Hold rating on Constellation Pharmaceuticals (NASDAQ:CNST) on Monday, setting a price target of $34, which is approximately 0.47% above the...
Investing.com – U.S. stocks were higher after the close on Wednesday, as gains in the Oil & Gas, Telecoms and Utilities sectors led shares higher. At the close in NYSE, the Dow...
Brookline Capital Markets analyst Leah R. Cann reiterated a Buy rating on Constellation Pharmaceuticals (NASDAQ:CNST) on Wednesday, setting a price target of $40, which is...
One stock that might be an intriguing choice for investors right now is Constellation Pharmaceuticals, Inc. (NASDAQ:CNST) . This is because this security in the Medical -...
The S&P 500 and Nasdaq indexes hit fresh record highs on Dec 26 on U.S.-China trade deal hopes. The deal is widely expected to be signed in early January. Robust holiday season...
The biotech space of the broad healthcare sector outperformed others in November, courtesy of a series of positive news including study results, regulatory backdrop and deal...
Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics to address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance. The company’s product candidates include Pelabresib that is in Phase 3 clinical trials for the treatment of patients with myelofibrosis in combination with ruxolitinib. It is also developing CPI-0209 that is in Phase 1 dose escalation portion of a Phase 1/2 clinical trial to treat solid tumors; and CPI-482, which is in preclinical stage for cancer patients. The company was formerly known as Epigenetix, Inc. and changed its name to Constellation Pharmaceuticals, Inc. in March 2008. Constellation Pharmaceuticals, Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts. As of July 15, 2021, Constellation Pharmaceuticals, Inc. operates as a subsidiary of MorphoSys AG.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 207.05 | 207.79 | 197.23 | +11.77 | +6.03% | 148.03M | NASDAQ | |||
| 164.80 | 164.82 | 162.13 | +2.44 | +1.50% | 37.03M | NASDAQ | |||
| 62.02 | 62.25 | 61.87 | +0.17 | +0.27% | 6.64M | NYSE | |||
| 210.93 | 211.09 | 206.77 | +3.09 | +1.49% | 17.88M | NASDAQ | |||
| 103.25 | 103.29 | 101.05 | +2.37 | +2.34% | 20.30M | NASDAQ | |||
| 288.27 | 288.44 | 283.03 | +4.22 | +1.49% | 18.85M | NASDAQ | |||
| 40.53 | 40.60 | 40.28 | +0.15 | +0.38% | 10.67M | NYSE | |||
| 98.13 | 98.25 | 95.27 | +0.25 | +0.26% | 45.76M | NASDAQ | |||
| 103.17 | 103.29 | 101.95 | +1.17 | +1.15% | 35.17M | NASDAQ | |||
| 165.98 | 166.68 | 164.29 | +3.31 | +2.03% | 731.81K | NASDAQ | |||
| 277.07 | 278.34 | 271.05 | +3.24 | +1.18% | 34.31M | NASDAQ | |||
| 8.45 | 8.48 | 8.09 | +0.29 | +3.62% | 20.53M | NYSE | |||
| 103.68 | 103.71 | 101.44 | +2.36 | +2.33% | 16.75M | NASDAQ | |||
| 47.87 | 48.13 | 45.95 | +1.36 | +2.92% | 10.90M | NYSE | |||
| 10.27 | 10.275 | 10.27 | 0.00 | 0.00% | 0.00 | NYSE |